Page last updated: 2024-11-05

trimethoprim and Lymphoma of Mucosa-Associated Lymphoid Tissue

trimethoprim has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sankaranarayanan, V1
Zeidalski, TM1
Chitkara, RK1
Oscier, D1
Bramble, J1
Hodges, E1
Wright, D1

Other Studies

2 other studies available for trimethoprim and Lymphoma of Mucosa-Associated Lymphoid Tissue

ArticleYear
A 55-year-old smoker with a persistent right lower lobe infiltrate.
    Chest, 2005, Volume: 127, Issue:6

    Topics: Biopsy, Needle; Bronchoscopy; Diagnosis, Differential; Follow-Up Studies; Gram-Negative Bacterial In

2005
Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Cephradine; Drug Therapy, Combination; Female; Humans; Lymphoma, B-Cell

2002